A CCEPTED MANUSCRIPT
Supplementary table 2. Discontinued subjects overview.
Subject ID
Trial product taken
Aspirin taken
Baseline Lewis score
Reason for trial discontinuation
Bif195/placebo
1013
Subject became pregnant. Contraindicates continuation.
Placebo
yes
yes
0
1026
Withdrawal for personal reasons
Placebo
yes
yes
184
1029
Baseline VCE capsule did not reach caecum. Contraindicates continuation.
Bif195
No
No
-
1042
Baseline VCE capsule retained in stomach. Contraindicates continuation.
Placebo
No
No
-
1048
Withdrawal for personal reasons
Bif195
yes
yes
0
1077
Baseline VCE capsule retained in stomach. Contraindicates continuation.
Placebo
No
No
-
1083
Baseline VCE capsule did not reach caecum. Contraindicates continuation.
Placebo
No
No
-
1089
SAE due to prolonged hospitalisation (back pain). Event unrelated to intake of trial product.
Placebo
yes
yes
67.5
1108
Withdrawal for personal reasons
Bif195
yes
yes
67.5
Supplementary Figure 1: Trial design.
MANUSCRIPT
2
Powered by FlippingBook